Unlocking Movement Potential: Enhancing Parkinson's Disease Treatment With Robotic EksoSkeleton
NCT: NCT06225830 · ACTIVE_NOT_RECRUITING
Brief Summary
The goal of this study is to see how well therapy with the Eksobionic Exoskeleton (Esko) works for people with Parkinson's disease (PWPD). Esko is a robotic device that provides high repetition and intensity training. The investigators will examine its impact on walking, balance, and quality of life before, during and after an eight-week intervention program. The results will lay the groundwork for future trials, potentially leading to long-term improvements in mobility and quality of life for PWPD.
Frequently Asked Questions
What is Unlocking Movement Potential: Enhancing Parkinson's Disease Treatment With Robotic EksoSkeleton?
Unlocking Movement Potential: Enhancing Parkinson's Disease Treatment With Robotic EksoSkeleton is a clinical trial registered under NCT06225830. Current status: ACTIVE_NOT_RECRUITING.
What is the status of NCT06225830?
The current status of NCT06225830 (Unlocking Movement Potential: Enhancing Parkinson's Disease Treatment With Robotic EksoSkeleton) is: ACTIVE_NOT_RECRUITING.
When did Unlocking Movement Potential: Enhancing Parkinson's Disease Treatment With Robotic EksoSkeleton start?
Unlocking Movement Potential: Enhancing Parkinson's Disease Treatment With Robotic EksoSkeleton started on 2024-06-04.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.